| Stock Price Performance - 12 Largest Negative One-Day Changes | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of Event |
After Event Date (Not Including Day of Selected Event) |
||||||||||||||||
| Date | Note | Day-Of Move | Opening Gap | % Open-to-High | % Open-to-Low | Drift Open-to-Close | 1 Day | 2 Days | 3 Days | 1 Week | 2 Weeks | ||||||
| 19-Dec-2025 [Stock -23.7%] |
Headline Cassava Sciences drops on delay for epilepsy study (19-Dec-2025, 12:00 AM Seeking Alpha News) |
-23.7% | |||||||||||||||
| 25-Mar-2025 [Stock -32.1%] |
Press Release Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data (25-Mar-2025, 8:05 AM Globe Newswire) HeadlinesCassava to phase out Alzheimer’s program by Q2 (25-Mar-2025, 12:00 AM Seeking Alpha News) 4 stocks to watch on Tuesday: GME, TSLA, SAVA and CCI (25-Mar-2025, 12:00 AM Seeking Alpha News) |
-32.1% | |||||||||||||||
| 25-Nov-2024 [Stock -83.8%] |
Press Releases Cassava Sciences to Hold Corporate Update on November 25th (24-Nov-2024, 8:01 PM Globe Newswire) Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints (25-Nov-2024, 7:30 AM Globe Newswire) HeadlinesCassava plummets 86% as simufilam phase 3 Alzheimer's trial misses endpoints (25-Nov-2024, 12:00 AM Seeking Alpha News) Biggest stock movers Monday: BCOV, BHVN, SAVA, ALAR, and more (25-Nov-2024, 12:00 AM Seeking Alpha News) |
-83.8% | |||||||||||||||
| 22-Nov-2024 [Stock -17.7%] |
-17.7% | ||||||||||||||||
| 9-Aug-2024 [Stock -16.0%] |
Day After EarningsSAVA released earnings 8-Aug-2024 BMOPress Release Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates (8-Aug-2024, 8:00 AM Globe Newswire) HeadlinesCassava Sciences GAAP EPS of $0.13 (8-Aug-2024, 12:00 AM Seeking Alpha News) Cassava Sciences estimates $40M loss contingency to resolve SEC simufilam probe (8-Aug-2024, 12:00 AM Seeking Alpha News) |
-16.0% | |||||||||||||||
| 6-Aug-2024 [Stock -13.1%] |
Press Release Cassava Sciences Mourns the Death of Board Member Sanford "Sandy" Robertson (5-Aug-2024, 9:01 AM Globe Newswire) |
-13.1% | |||||||||||||||
| 17-Jul-2024 [Stock -29.3%] |
Press Release Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives (17-Jul-2024, 8:00 AM Globe Newswire) Headlines4 stocks to watch on Wednesday: JNJ, UAL and more (17-Jul-2024, 12:00 AM Seeking Alpha News) Cassava Sciences stock tumbles as CEO Remi Barbier resigns (17-Jul-2024, 12:00 AM Seeking Alpha News) |
-29.3% | |||||||||||||||
| 28-Jun-2024 [Stock -34.8%] |
Press Release Cassava Sciences Issues Statement on Former Science Advisor (28-Jun-2024, 3:58 PM Globe Newswire) |
-34.8% | |||||||||||||||
| 16-Oct-2023 [Stock -14.9%] |
-14.9% | ||||||||||||||||
| 13-Oct-2023 [Stock -15.3%] |
Press Release Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press (12-Oct-2023, 11:43 PM Globe Newswire) |
-15.3% | |||||||||||||||
| 5-Jul-2023 [Stock -13.0%] |
Press Release Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer's Disease (5-Jul-2023, 9:15 AM Globe Newswire) |
-13.0% | |||||||||||||||
| 24-Jan-2023 [Stock -19.2%] |
Press Release Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer's Disease (24-Jan-2023, 9:15 AM Globe Newswire) |
-19.2% | |||||||||||||||
| Simple Average Returns - 12 Largest Negative One-Day Changes | |||||||||||||||||
| Avg Return | |||||||||||||||||
| Positive Occurrences | |||||||||||||||||
| Negative Occurrences | |||||||||||||||||
| Absolute Average Returns - 12 Largest Negative One-Day Changes | |||||||||||||||||
| Abs Avg Return | |||||||||||||||||
| Max Abs Return | |||||||||||||||||
| Min Abs Return | |||||||||||||||||
| Median, Minimum, and Maximum Returns - 12 Largest Negative One-Day Changes | |||||||||||||||||
| Median Return | |||||||||||||||||
| Max Positive Return | |||||||||||||||||
| Max Negative Return | |||||||||||||||||